Home › Companies › Edgewise Therapeutics, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Edgewise Therapeutics, Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 4, 2026: 5 items on Edgewise Therapeutics, Inc.’s Form 8-K, filed June 5, 2026: 3 elected · 2 approved.
Significant dissent: 2 directors (35.0%, 29.7% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13F, 7.7%, as of September 30, 2026)
Explore Edgewise Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Edgewise Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Laura Brege | 87,300,827 | -- | -- | 3,822,867 | -- | 96% | Elected | — |
| Elect Director: Badreddin Edris, Ph.D. | 64,082,681 | -- | -- | 27,041,013 | -- | 70% | Elected | — |
| Elect Director: Jonathan Root, M.D. | 59,213,781 | -- | -- | 31,909,913 | -- | 65% | Elected | — |
| 2. Ratification of the Appointment of Independent Registered Public Accounting Firm | 99,637,228 | 1,123 | 578,031 | -- | -- | 99.9% | Approved | — |
| 3. Advisory Vote on the Compensation of the Company's Named Executive Officers | 87,055,111 | 3,491,326 | 577,257 | -- | -- | 96% | Approved | — |
Source: Edgewise Therapeutics, Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
247 asset managers disclosed a vote on at least one Edgewise Therapeutics, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Badreddin Edris, Ph.D.
Edgewise Therapeutics, Inc.’s own tally for this item (“Elect Director: Badreddin Edris, Ph.D.”): 64,082,681 for, 27,041,013 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of three Class II Directors Each director nominee was duly elected to serve until the 2029 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.”
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 9,011,914 for, 6,004,615 withheld, 4,004,741 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,302,779 | 0 | 41 | 0 | For |
| BlackRock | 0 | 0 | 3,540,101 | 0 | Abstain |
| Fidelity | 1,516,739 | 0 | 0 | 1,081,850 | Mixed |
| JANUS INVESTMENT FUND | 659,237 | 0 | 0 | 764,760 | Mixed |
| Victory Capital | 0 | 0 | 0 | 903,702 | Withhold |
| American Century | 0 | 0 | 0 | 881,302 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 658,224 | Withhold |
| Charles Schwab | 596,640 | 0 | 0 | 0 | For |
| AllianceBernstein | 518,283 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 370,215 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 297,886 | Withhold |
| Equitable | 192,828 | 0 | 0 | 95,732 | Mixed |
| TIAA | 0 | 0 | 0 | 259,211 | Withhold |
| State Street | 190,046 | 0 | 0 | 144 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 0 | 151,637 | 0 | Abstain |
| Prudential/PGIM | 0 | 0 | 0 | 136,422 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 131,645 | Withhold |
| Principal | 125,329 | 0 | 0 | 4,555 | For |
| Jackson National | 0 | 0 | 127,263 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 109,592 | 0 | Abstain |
| Lincoln Financial | 52,134 | 0 | 0 | 39,310 | Mixed |
| RBB FUND, INC. | 0 | 0 | 0 | 90,077 | Withhold |
| Allspring | 0 | 0 | 0 | 87,556 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 87,326 | Withhold |
| Neuberger Berman | 77,373 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
65% Majority: yes · of votes cast
Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Jonathan Root, M.D.
Edgewise Therapeutics, Inc.’s own tally for this item (“Elect Director: Jonathan Root, M.D.”): 59,213,781 for, 31,909,913 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of three Class II Directors Each director nominee was duly elected to serve until the 2029 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.”
Support: 65% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 8,037,314 for, 6,978,976 withheld, 4,004,981 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,299,650 | 0 | 51 | 3,119 | For |
| BlackRock | 0 | 0 | 3,540,101 | 0 | Abstain |
| Fidelity | 1,516,739 | 0 | 0 | 1,081,850 | Mixed |
| JANUS INVESTMENT FUND | 1,423,997 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 903,702 | Withhold |
| American Century | 0 | 0 | 0 | 881,302 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 658,224 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 596,640 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 518,283 | Withhold |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 370,215 | Withhold |
| Dimensional | 0 | 0 | 0 | 297,886 | Withhold |
| Equitable | 0 | 0 | 0 | 288,560 | Withhold |
| TIAA | 259,211 | 0 | 0 | 0 | For |
| State Street | 258 | 0 | 0 | 189,932 | Withhold |
| TRUST FOR PROFESSIONAL MANAGERS | 0 | 0 | 151,637 | 0 | Abstain |
| Prudential/PGIM | 0 | 0 | 0 | 136,422 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 131,645 | Withhold |
| Principal | 0 | 0 | 0 | 129,884 | Withhold |
| Jackson National | 0 | 0 | 127,263 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 109,592 | 0 | Abstain |
| Lincoln Financial | 6,134 | 0 | 0 | 85,310 | Mixed |
| RBB FUND, INC. | 0 | 0 | 0 | 90,077 | Withhold |
| Allspring | 0 | 0 | 0 | 87,556 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 87,326 | Withhold |
| Neuberger Berman | 77,373 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Elect the directors named in the attached Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: Laura Brege
Edgewise Therapeutics, Inc.’s own tally for this item (“Elect Director: Laura Brege”): 87,300,827 for, 3,822,867 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of three Class II Directors Each director nominee was duly elected to serve until the 2029 annual meeting of stockholders and until their successor is duly elected and qualified, subject to earlier resignation or removal.”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 17,565,125 for, 1,414,935 withheld, 41,210 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,299,693 | 0 | 8 | 3,119 | For |
| BlackRock | 3,540,101 | 0 | 0 | 0 | For |
| Fidelity | 1,540,433 | 0 | 0 | 1,058,156 | Mixed |
| JANUS INVESTMENT FUND | 1,423,997 | 0 | 0 | 0 | For |
| Victory Capital | 903,702 | 0 | 0 | 0 | For |
| American Century | 881,302 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 658,224 | 0 | 0 | 0 | For |
| Charles Schwab | 596,640 | 0 | 0 | 0 | For |
| AllianceBernstein | 518,283 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 370,215 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 297,886 | Withhold |
| Equitable | 288,560 | 0 | 0 | 0 | For |
| TIAA | 259,211 | 0 | 0 | 0 | For |
| State Street | 190,190 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 151,637 | 0 | 0 | 0 | For |
| Prudential/PGIM | 132,040 | 0 | 0 | 4,382 | For |
| AIG/SunAmerica | 131,645 | 0 | 0 | 0 | For |
| Principal | 129,884 | 0 | 0 | 0 | For |
| Jackson National | 113,413 | 0 | 13,850 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 109,592 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,444 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 90,077 | 0 | 0 | 0 | For |
| Allspring | 87,556 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 87,326 | 0 | 0 | 0 | For |
| Neuberger Berman | 77,373 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
Edgewise Therapeutics, Inc.’s own tally for this item (“3. Advisory Vote on the Compensation of the Company's Named Executive Officers”): 87,055,111 for, 3,491,326 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory Vote on the Compensation of the Company's Named Executive Officers”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,302,813 | 5 | 1 | 0 | For |
| BlackRock | 3,540,101 | 0 | 0 | 0 | For |
| Fidelity | 1,540,433 | 1,058,156 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 1,423,997 | 0 | 0 | 0 | For |
| Victory Capital | 903,702 | 0 | 0 | 0 | For |
| American Century | 0 | 881,302 | 0 | 0 | Against |
| DRIEHAUS MUTUAL FUNDS | 658,224 | 0 | 0 | 0 | For |
| Charles Schwab | 596,640 | 0 | 0 | 0 | For |
| AllianceBernstein | 518,283 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 370,215 | 0 | 0 | 0 | For |
| Dimensional | 297,886 | 0 | 0 | 0 | For |
| Equitable | 288,560 | 0 | 0 | 0 | For |
| TIAA | 259,211 | 0 | 0 | 0 | For |
| State Street | 190,183 | 7 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 138,509 | 13,128 | 0 | 0 | Mixed |
| Prudential/PGIM | 136,422 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 131,645 | 0 | 0 | 0 | For |
| Principal | 129,884 | 0 | 0 | 0 | For |
| Jackson National | 127,263 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 109,592 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,444 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 90,077 | 0 | 0 | 0 | For |
| Allspring | 87,556 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 87,326 | 0 | 0 | 0 | For |
| Neuberger Berman | 77,373 | 0 | 0 | 0 | For |
Fund voting reports, all 72 managers: 16,967,935 for, 2,003,771 against, 4,800 withheld, 31,644 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 15,518,492 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 10,399,068 | 0 | 0 | 0 | For |
| Janus Henderson | 7,384,469 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 6,256,954 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 5,350,000 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 4,330,263 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,877,926 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 2,432,969 | 0 | 0 | 0 | For |
| BlackRock | 2,360,104 | 17,483 | 0 | 0 | For |
| Cormorant Asset Management, LP | 1,922,264 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,761,673 | 0 | 0 | 0 | For |
| State Street | 1,572,156 | 2,314 | 0 | 0 | For |
| AllianceBernstein | 1,548,713 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 1,429,915 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 1,157,401 | 0 | 0 | 0 | For |
| Fidelity | 0 | 1,065,086 | 0 | 0 | Against |
| American Century | 0 | 974,645 | 0 | 0 | Against |
| First Light Asset Management, LLC | 878,654 | 0 | 0 | 0 | For |
| Victory Capital | 856,333 | 0 | 0 | 0 | For |
| Aberdeen | 826,059 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 651,820 | 0 | 0 | 0 | For |
| Vanguard | 606,314 | 0 | 0 | 0 | For |
| Charles Schwab | 604,745 | 0 | 0 | 0 | For |
| Artisan | 578,010 | 0 | 0 | 0 | For |
| Integral Health Asset Management, LLC | 562,244 | 0 | 0 | 0 | For |
Institutional-manager reports, all 197 managers: 76,854,450 for, 2,805,549 against, 61 abstained, 370 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Description as filed by funds: RATIFY THE SELECTION OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Edgewise Therapeutics, Inc.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 99,637,228 for, 1,123 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 18,968,295 for, 31,644 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,302,819 | 0 | 1 | 0 | For |
| BlackRock | 3,540,101 | 0 | 0 | 0 | For |
| Fidelity | 2,598,589 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,423,997 | 0 | 0 | 0 | For |
| Victory Capital | 903,702 | 0 | 0 | 0 | For |
| American Century | 881,302 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 658,224 | 0 | 0 | 0 | For |
| Charles Schwab | 596,640 | 0 | 0 | 0 | For |
| AllianceBernstein | 518,283 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 370,215 | 0 | 0 | 0 | For |
| Dimensional | 297,886 | 0 | 0 | 0 | For |
| Equitable | 288,560 | 0 | 0 | 0 | For |
| TIAA | 259,211 | 0 | 0 | 0 | For |
| State Street | 190,190 | 0 | 0 | 0 | For |
| TRUST FOR PROFESSIONAL MANAGERS | 151,637 | 0 | 0 | 0 | For |
| Prudential/PGIM | 136,422 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 131,645 | 0 | 0 | 0 | For |
| Principal | 129,884 | 0 | 0 | 0 | For |
| Jackson National | 127,263 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 109,592 | 0 | 0 | 0 | For |
| Lincoln Financial | 91,444 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 90,077 | 0 | 0 | 0 | For |
| Allspring | 87,556 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 87,326 | 0 | 0 | 0 | For |
| Neuberger Berman | 77,373 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 107,481,522 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.00% |
| 2 | BlackRock | 3.29% |
| 3 | Fidelity | 2.42% |
| 4 | JANUS INVESTMENT FUND | 1.32% |
| 5 | Victory Capital | 0.84% |
| 6 | American Century | 0.82% |
| 7 | DRIEHAUS MUTUAL FUNDS | 0.61% |
| 8 | Charles Schwab | 0.56% |
| 9 | AllianceBernstein | 0.48% |
| 10 | AB DISCOVERY GROWTH FUND, INC. | 0.34% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 14.44% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 9.68% |
| 3 | Janus Henderson | 6.87% |
| 4 | Paradigm Biocapital Advisors LP | 5.82% |
| 5 | Novo Holdings A/S | 4.98% |
| 6 | Siren, L.L.C. | 4.03% |
| 7 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2.68% |
| 8 | PERCEPTIVE ADVISORS LLC | 2.26% |
| 9 | BlackRock | 2.21% |
| 10 | Cormorant Asset Management, LP | 1.79% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Paradigm BioCapital Advisors LP | 10,215,455 | 9.50% | Schedule 13G, filed August 14, 2026 |
| BlackRock | 6,472,991 | 6.02% | Form 13F, quarter ended March 31, 2026 |
| JANUS HENDERSON GROUP PLC | 5,915,556 | 5.50% | Schedule 13G, filed May 15, 2026 |
| Novo Holdings A/S | 5,350,000 | 4.98% | Schedule 13D, filed April 27, 2026 |
| Vanguard Group | 4,871,624 | 4.53% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 2,910,881 | 2.71% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 1,789,819 | 1.67% | Form 13F, quarter ended March 31, 2026 |
| State Street | 1,716,823 | 1.60% | Form 13F, quarter ended March 31, 2026 |
| Dimensional Fund Advisors | 1,219,717 | 1.13% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 1,017,052 | 0.95% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 107,481,522 shares outstanding, as reported by Edgewise Therapeutics, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Edgewise Therapeutics, Inc.'s shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 247 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,362 separate fund positions. On the most widely held item on that ballot — CONDUCT AN ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — Edgewise Therapeutics, Inc.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Edgewise Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Edgewise Therapeutics, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Edgewise Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Edgewise Therapeutics (EWTX) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/edgewise-therapeutics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.